Clinical trial
COVID-19 Antibody Responses in Cystic Fibrosis:CAR-CF
NCT04992234 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Antibody Responses in Cystic Fibrosis:CAR-CF
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2021
- Completion date
- April 14, 2025
- Enrollment
- 113 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, cystic fibrosis